Myocardion ™ (PROGENITOR CELLS OF MESODERMAL LINEAGE [PML])

CLINICAL TRIAL READY :

PML cells are being investigated as a treatment for patients with mild to moderate heart failure.

STATUS :

PML cells are ready to enter European clinical trials as a treatment for patients with mild to moderate heart failure.